AI-generated summary
The authors conducted a bibliometric analysis of 4907 photobiomodulation publications from the Web of Science Core Collection between 2006 and 2025, using knowledge-mapping software and PubMed clinical trial data. They report steady growth in publication output, with Brazil contributing the largest share and Alzheimer's disease emerging as a rapidly growing niche topic. The authors note that the field needs standardized treatment parameters and long-term clinical validation.
- Studies included
- 4,907
- Who or what was studied
- Photobiomodulation publications indexed in the Web of Science Core Collection, 2006 to 2025
- Limits stated in the abstract
- The abstract describes a bibliometric analysis of publication records rather than clinical outcomes, so it cannot establish whether photobiomodulation is effective.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Light-emitting diode, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.